Annual SGA
$17.01 M
-$4.11 M-19.46%
December 31, 2023
Summary
- As of February 7, 2025, ACHL annual SGA is $17.01 million, with the most recent change of -$4.11 million (-19.46%) on December 31, 2023.
- During the last 3 years, ACHL annual SGA has risen by +$5.91 million (+53.26%).
- ACHL annual SGA is now -22.58% below its all-time high of $21.97 million, reached on December 31, 2021.
Performance
ACHL SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$4.02 M
-$143.00 K-3.43%
September 1, 2024
Summary
- As of February 7, 2025, ACHL quarterly SGA is $4.02 million, with the most recent change of -$143.00 thousand (-3.43%) on September 1, 2024.
- Over the past year, ACHL quarterly SGA has increased by +$399.00 thousand (+11.02%).
- ACHL quarterly SGA is now -39.56% below its all-time high of $6.65 million, reached on December 31, 2021.
Performance
ACHL Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.13 B
-$66.88 M-6.30%
September 1, 2024
Summary
- As of February 7, 2025, ACHL TTM SGA is -$1.13 billion, with the most recent change of -$66.88 million (-6.30%) on September 1, 2024.
- Over the past year, ACHL TTM SGA has dropped by -$1.15 billion (-6737.57%).
- ACHL TTM SGA is now -1846.12% below its all-time high of -$58.01 million.
Performance
ACHL TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ACHL Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.5% | +11.0% | -6737.6% |
| 3 y3 years | +53.3% | -26.0% | -4840.6% |
| 5 y5 years | +261.7% | -26.0% | -4840.6% |
ACHL Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -22.6% | at low | -39.6% | +11.0% | -197.3% | at low |
| 5 y | 5-year | -22.6% | +261.7% | -39.6% | +131.6% | -1846.1% | at low |
| alltime | all time | -22.6% | +261.7% | -39.6% | +131.6% | -1846.1% | at low |
Achilles Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.02 M(-3.4%) | $15.97 M(-2.2%) |
| Jun 2024 | - | $4.16 M(+0.1%) | $16.33 M(-0.9%) |
| Mar 2024 | - | $4.16 M(+14.8%) | $16.48 M(-3.1%) |
| Dec 2023 | $17.01 M(-19.5%) | $3.62 M(-17.4%) | $17.01 M(-1.9%) |
| Sep 2023 | - | $4.38 M(+1.5%) | $17.34 M(-5.7%) |
| Jun 2023 | - | $4.32 M(-7.8%) | $18.40 M(-7.3%) |
| Mar 2023 | - | $4.68 M(+18.4%) | $19.85 M(-6.0%) |
| Dec 2022 | $21.12 M | $3.96 M(-27.2%) | $21.12 M(-11.3%) |
| Sep 2022 | - | $5.44 M(-5.8%) | $23.82 M(+1.7%) |
| Jun 2022 | - | $5.77 M(-3.1%) | $23.42 M(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $5.96 M(-10.5%) | $23.09 M(+5.1%) |
| Dec 2021 | $21.97 M(+98.0%) | $6.65 M(+32.0%) | $21.97 M(+14.0%) |
| Sep 2021 | - | $5.04 M(-7.4%) | $19.28 M(+11.8%) |
| Jun 2021 | - | $5.45 M(+12.7%) | $17.24 M(+21.5%) |
| Mar 2021 | - | $4.83 M(+22.1%) | $14.19 M(+27.9%) |
| Dec 2020 | $11.10 M(+136.0%) | $3.96 M(+31.5%) | $11.10 M(+55.4%) |
| Sep 2020 | - | $3.01 M(+25.6%) | $7.14 M(+72.8%) |
| Jun 2020 | - | $2.40 M(+38.0%) | $4.13 M(+138.0%) |
| Mar 2020 | - | $1.74 M | $1.74 M |
| Dec 2019 | $4.70 M | - | - |
FAQ
- What is Achilles Therapeutics annual SGA?
- What is the all time high annual SGA for Achilles Therapeutics?
- What is Achilles Therapeutics annual SGA year-on-year change?
- What is Achilles Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Achilles Therapeutics?
- What is Achilles Therapeutics quarterly SGA year-on-year change?
- What is Achilles Therapeutics TTM SGA?
- What is the all time high TTM SGA for Achilles Therapeutics?
- What is Achilles Therapeutics TTM SGA year-on-year change?
What is Achilles Therapeutics annual SGA?
The current annual SGA of ACHL is $17.01 M
What is the all time high annual SGA for Achilles Therapeutics?
Achilles Therapeutics all-time high annual SGA is $21.97 M
What is Achilles Therapeutics annual SGA year-on-year change?
Over the past year, ACHL annual SGA has changed by -$4.11 M (-19.46%)
What is Achilles Therapeutics quarterly SGA?
The current quarterly SGA of ACHL is $4.02 M
What is the all time high quarterly SGA for Achilles Therapeutics?
Achilles Therapeutics all-time high quarterly SGA is $6.65 M
What is Achilles Therapeutics quarterly SGA year-on-year change?
Over the past year, ACHL quarterly SGA has changed by +$399.00 K (+11.02%)
What is Achilles Therapeutics TTM SGA?
The current TTM SGA of ACHL is -$1.13 B
What is the all time high TTM SGA for Achilles Therapeutics?
Achilles Therapeutics all-time high TTM SGA is -$58.01 M
What is Achilles Therapeutics TTM SGA year-on-year change?
Over the past year, ACHL TTM SGA has changed by -$1.15 B (-6737.57%)